Back to dataset
Inflammatory bowel disease national clinical audit of biological therapies (2015) Adult biological therapies data - IBD audit 2015
You're previewing the first 4 rows of this file.
Download this file| Health board / Trust name | Sitename | Participation status | CrohnÕs disease patients Ð time from diagnosis to initial treatment, years, Median (IQR) | Initial treatment Harvey Bradshaw Index, Median (IQR) | CrohnÕs disease patients Ð remission achieved | CrohnÕs disease patients Ð On concomitant immunosuppression at start of treatment | CrohnÕs disease patients with adverse event recorded at 3 month follow-up | All patients ÐPROMs completed at start of treatment |
|---|---|---|---|---|---|---|---|---|
| Aintree University Hospitals NHS Foundation Trust | Aintree University Hospital | Participant | n=22, 3 (1, 8) | n<6 | n<6 | 14/22 (64%) | 1/8 (13%) | 2/32 (6%) |
| Airedale NHS Foundation Trust | Airedale General Hospital* | Participant | n=28, 2 (1, 9) | n=26, 10 (7, 12) | 6/10 (60%) | 5/25 (20%) | 2/11 (18%) | 17/38 (45%) |
| Barking, Havering and Redbridge Hospitals NHS Trust | King George Hospital and Queens Hospital combined | Participant | n=46, 5 (1, 10) | n=22, 11 (7, 13) | 5/7 (71%) | 27/46 (59%) | 1/26 (4%) | 0/63 (0%) |
| Barnsley Hospital NHS Foundation Trust | Barnsley District General Hospital | Participant | n=50, 3 (1, 12) | n<6 | n=0 | 22/51 (43%) | 1/24 (4%) | 0/68 (0%) |